Benchworks Names Emil C. Andrusko Senior Vice President of Pharmaceutical Strategy

Andrusko to be responsible for market development with new clients in the biopharmaceutical market.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Emil's extensive knowledge of pharmaceutical marketing honed by decades of experience will greatly contribute to the development of highly effective strategy, positioning and top-tier campaigns.

Chestertown, Maryland (PRWEB) May 08, 2014

Benchworks is pleased to announce that Emil C. Andrusko was recently named Senior Vice President of Pharmaceutical Strategy. In this position, he will be primarily responsible for market development with new clients within the biopharmaceutical market, as well as strategic planning and direction for a variety of existing clients.

Emil Andrusko has 30 years of sales and marketing experience in the pharmaceutical industry with Wyeth and Pfizer. He has held numerous executive sales and marketing leadership positions in numerous therapeutic categories and has a track record of innovation and driving growth for brands.

“I am very pleased to have Emil join the Benchworks leadership team,” Benchworks CEO Thad Bench said. “Emil's extensive knowledge of pharmaceutical marketing honed by decades of experience will greatly contribute to the development of highly effective strategy, positioning and top-tier campaigns for our clients.”

Benchworks, a comprehensive marketing services firm headquartered in Chestertown, Maryland, was founded in 1991. The company specializes in the design, production, and launch of complete marketing and branding services. Clients include a wide variety of companies in the pharmaceutical, beverage, manufacturing, marine, tourism and education industries in North America and Europe.

For more information, visit http://www.benchworks.com, or call 800-536-4670.


Contact